AKT1 and hepatocellular carcinoma: Such a physiological mechanism that may contribute to the resistance against AKT/mTOR treatment would be in line with our observation from the clonality studies of RGB-marked cells indicating that large numbers of HCC cells become resistant to AKT/mTOR inhibitor treatment.